Clinical trial
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep…
NCT00311090 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00311090 |
|---|---|
| Title | Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs |
| Official title | International, Multicenter, Randomized, Parallel Group, Double-blind Study, in Patients With Acute Symptomatic Deep Vein Thrombosis of the Lower Limbs, Demonstrating the Bioequipotency at Steady State of Equimolar Doses of SSR126517E (3.0 mg) Once a Week and SR34006 (2.5 mg) Once a Week, Documenting… |
| Acronym | EQUINOX |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Deep Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Idrabiotaparinux sodium, Idraparinux sodium, Avidin, Placebo (for Avidin) |
| Enrollment | 757 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Mar 21, 2016 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Israel, Italy, Mexico and 8 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: